Active, Not Recruiting
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Research Site Palmdale, California, United States
- Research Site Colorado Springs, Colorado, United States
- Research Site Miami, Florida, United States
- Research Site Boston, Massachusetts, United States